Introduction {#s1}
============

Gene expression is determined through a combination of transcriptional and post-transcriptional regulation. While transcriptional regulation is well studied, less is known about how post-transcriptional events contribute to overall mRNA levels. Mammalian mRNAs display a wide range of half-lives ranging from minutes to over a day ([@bib70]). The wide range of mRNA stabilities are regulated by both intrinsic sequence features as well as the binding of regulatory factors such as microRNAs and RNA-binding proteins ([@bib15]; [@bib30]; [@bib79]). However, the identity and how such features and regulatory factors impact mRNA stability are not well understood.

One process that is intimately linked to mRNA stability is translation ([@bib67]). Quality control mechanisms such as nonsense mediated decay, no go decay, and non-stop decay sense aberrant translation and lead to mRNA degradation ([@bib56]; [@bib73]). Translation initiation and elongation can also influence mRNA stability ([@bib34]). In yeast, inhibition of translation initiation through either 5' cap binding mutants or drug treatment leads to accelerated mRNA decay ([@bib11]; [@bib34]; [@bib71]). Conversely, treatment with cycloheximide, which blocks ribosome elongation, stabilizes mRNAs ([@bib5]; [@bib11]; [@bib34]). The mechanisms linking translation to mRNA stability are poorly understood.

MiRNAs are small, non-coding RNAs that bind to the 3' UTR of their target transcripts to inhibit translation and/or induce mRNA destabilization ([@bib24]; [@bib38]). Whether they primarily impact translation or mRNA degradation has been intensely debated ([@bib37]; [@bib38]). The impact of miRNAs on the translation of endogenous transcripts has been measured using ribosome profiling, which measures the ratio of ribosome protected fragments to input mRNA (this ratio is termed translational efficiency). Simultaneous RNA-Seq and ribosome profiling experiments across a number of contexts show that miRNAs produce larger changes in mRNA levels than in translational efficiency, leading to the suggestion that mRNA destabilization is the dominant effect of miRNA repression ([@bib22]; [@bib29]). However, in other studies, it has been suggested that miRNAs primarily inhibit translation. For example, in the early zebrafish embryo, ribosome profiling and RNA-Seq show that miRNAs induce translational repression without mRNA destabilization ([@bib4]). Furthermore, experiments using miRNA reporters to examine the kinetics of miRNA repression suggest that translational repression precedes mRNA destabilization ([@bib7]; [@bib18]). These studies raise the question of whether translational repression is the direct mode of miRNA-driven suppression with mRNA destabilization being a secondary consequence. To resolve this question, it is important to genetically separate the two functions. However, despite extensive research, it is not known whether it is possible to decouple miRNA-induced translational repression and mRNA destabilization of endogenous transcripts in a cell where both occur.

The RNA-binding protein DDX6 and its yeast homolog DHH1 are DEAD box helicases that localize to P-bodies and stress granules. These proteins have been implicated in both translational repression and mRNA destabilization, suggesting that they may link these two processes ([@bib17]; [@bib59]). Tethering experiments in yeast that lack DCP2 or DCP1 demonstrate that DHH1 can repress translation upstream and independent of enhancing decapping ([@bib10]; [@bib74]). Tethering experiments in human cells demonstrate that DDX6 also represses translation ([@bib42]). Furthermore, DDX6 binds to components of the decapping complex, but exactly how this impacts translation and mRNA stability is unclear ([@bib2]; [@bib53]; [@bib75]). Additionally, through interactions with the CCR4-NOT complex and the decapping complex, DDX6 is thought to be involved in miRNA-mediated translational repression, but its exact role is not fully understood ([@bib14]; [@bib16]; [@bib49]; [@bib66]).

Here, we sought to understand how mRNA stability changes are linked to translation changes during early mammalian development. It has been suggested that up to 70% of the molecular changes during mouse embryonic stem cell (ESC) differentiation are due to post-transcriptional regulation ([@bib45]). Therefore, we measured and analyzed changes in mRNA stability and translational efficiency during ESC differentiation. Surprisingly, we found that the vast majority of molecular changes during this transition are driven by transcriptional, not post-transcriptional mechanisms. However, within self-renewing ESCs there was a wide range of mRNA stabilities. These stability differences correlated with translation levels. We generated *Ddx6* KO ESCs to determine whether DDX6 links translation to mRNA stability. Unlike its yeast homolog, DDX6 did not appear to play a general role in linking the two. However, its loss did lead to the translational upregulation of miRNA targets with little associated changes in mRNA stability. The resulting cells looked phenotypically and molecularly similar to cells deficient for all miRNAs. Therefore, the loss of DDX6 is able to separate the two central functions of miRNAs: translational repression and mRNA destabilization. Furthermore, these data show miRNA-induced translational repression alone can recapitulate many of the downstream consequences of miRNAs.

Results {#s2}
=======

Transcriptional changes drive expression changes during the ESC to EpiLC transition {#s2-1}
-----------------------------------------------------------------------------------

Previous work suggested that up to 70% of the molecular changes that occur during early ESC differentiation are due to post-transcriptional events ([@bib45]). In that work, differentiation was induced by expressing a shRNA to Nanog in ESCs grown in LIF. These conditions are associated with a heterogeneous population of cells ([@bib36]). To revisit this question, we turned to a reporter system and an optimized differentiation protocol that enables the homogenous differentiation of naive ESCs to formative epiblast like cells (EpiLC), which is representative of the transition from the pre- to post-implantation epiblast in vivo ([@bib13]; [@bib41]; [@bib55]) ([Figure 1A](#fig1){ref-type="fig"}). Using this system, we characterized the changes in mRNA expression, mRNA stability, and translation that occur during the transition. RNA-Seq showed 1890 genes significantly upregulated and 1532 genes significantly downregulated during the ESC to EpiLC transition ([Figure 1B and F](#fig1){ref-type="fig"}). Known naive markers were downregulated, while known primed markers were upregulated confirming robust differentiation ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) ([@bib8]).

![Transcriptional changes drive expression changes during the ESC to EpiLC transition.\
(**A**) Flow cytometry of the transition from naive embryonic stem cells (ESCs) (miR-302 GFP-, miR-290 mCherry+) to primed epiblast-like cells (EpiLCs) (miR-302 GFP+, miR-290 mCherry+). (**B**) MA plot of mRNA changes during the ESC to EpiLC transition. Significant changes are shown as red dots (Adjusted p value \< 0.05 and \|log2 fold change\| \> 1) in B, C, E. Dashed lines indicated a twofold change. (**C**) MA plot of mRNA stability changes during the ESC to EpiLC transition. (**D**) Correlation between changes in nascent transcription (4sU-labeled mRNA) and changes in mRNA levels during the ESC to EpiLC transition. The p value was calculated with correlation significance test. (**E**) MA plot of translational efficiency (TE) changes during the ESC to EpiLC transition. (**F**) The number of significant increases or decreases in transcription, mRNA levels, mRNA stability, and translational efficiency during the ESC to EpiLC transition. n = 3 for each ESC and EpiLC seq experiment. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.](elife-38014-fig1){#fig1}

To separate the contribution of transcription versus mRNA stability to changing mRNA levels during the ESC to EpiLC transition, we used metabolic labeling with 4-thiouridine (4sU) ([@bib20]; [@bib60]; [@bib78]). To measure transcription, nascent transcripts were labeled with a 30-min 4sU pulse, biotinylated, pulled down with streptavidin, and sequenced (4sU-Seq). To measure mRNA stability, total RNA-Seq was performed in parallel and the ratio of nascent RNA to total RNA was used to calculate relative stabilities for each gene ([@bib60]). To validate these findings, a subset of genes spanning a range of stabilities were measured using an alternative method where transcription was blocked with actinomycin D and mRNA levels followed over a time course by RT-qPCR ([Figure 1---figure supplement 1B and C](#fig1s1){ref-type="fig"}). The relative stabilities predicted by the two approaches were highly correlated. Given that the 4sU-Seq approach avoids the secondary effects associated with blocking all transcription, we used those data for genome-wide analysis ([@bib6]; [@bib46]). Surprisingly, the 4sU/total mRNA data showed very few changes in mRNA stability between the ESC and EpiLC states ([Figure 1C and F](#fig1){ref-type="fig"}). This lack of changes was not because of noise among the replicates, as biological replicates were well correlated ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}).

The general lack of changes in mRNA stability suggested that transcription is the dominant regulator of the changing mRNA levels during the ESC to EpiLC transition. Indeed, fold changes in total mRNA levels correlated extremely well with fold changes in 4sU-labeled nascent transcripts (Spearman's rho 0.88; p\<2.22\*10^−16^) ([Figure 1D](#fig1){ref-type="fig"}). Thus, nascent transcription, not mRNA stability, underlies the mRNA changes associated with the ESC to EpiLC transition.

Next, we asked whether changes in translation play an important role in the ESC to EpiLC transition. To measure translation of all genes, we performed ribosome profiling to collect Ribosome Protected Footprints (RPFs) and matched total mRNA ([@bib35]). As expected, RPFs showed a strong three nucleotide phasing of reads that was not present in the mRNA samples, confirming the quality of the data ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}). We calculated translation using the ratio of RPF/mRNA, also known as translational efficiency ([@bib35]). Global analysis showed very few changes in translational efficiencies between the ESC and EpiLC states ([Figure 1E and F](#fig1){ref-type="fig"}). Biological replicates were well correlated showing that the overall lack of changes is not due to noise between the replicates ([Figure 1---figure supplement 1F](#fig1s1){ref-type="fig"}). Therefore, like mRNA stability, there are few changes in translational efficiency in early ESC differentiation.

There is a wide range of RNA stabilities which are positively correlated with translation in ESCs {#s2-2}
-------------------------------------------------------------------------------------------------

Although there were minimal changes in mRNA stability during the ESC to EpiLC transition, there was a wide range of mRNA stabilities within ESCs. For example, between the 25th and 75th percentile of mRNA stability, there was a 3.2-fold difference in stability and between the top and bottom 1% of mRNA stability there was over a 64-fold difference ([Figure 2A](#fig2){ref-type="fig"}). To identify features that explain the range of mRNA stabilities observed, we performed multiple linear regression taking into account the following features that previous studies implicated in affecting mRNA stability: 3' UTR length, 5' UTR length, CDS length, 3' UTR GC content, 5' UTR GC content, CDS GC content, AU-rich elements (ARE), miRNA-binding sites, number of exons in the transcript, and upstream ORFs ([@bib11]; [@bib15]; [@bib72]). Combined, these features explained 25% of the variation in mRNA stability. To identify which features had the greatest impact on stability, we analyzed the correlation between each individual feature and mRNA stability ([Figure 2B](#fig2){ref-type="fig"}). 3' UTR length had the greatest impact and was negatively correlated with mRNA stability (Spearman's rho −0.3; p\<2.22\*10^−16^) ([Figure 2C](#fig2){ref-type="fig"}). To validate the impact of 3' UTRs on mRNA stability, we used a dual reporter system that contains a control GFP for normalization and a RFP with a cloned endogenous 3' UTR from 12 representative genes ([Figure 2D](#fig2){ref-type="fig"}) ([@bib12]). Flow cytometry analysis of cells expressing the reporter showed that the RFP/GFP ratio correlated well with the mRNA stability of the matching endogenous genes as measured by 4sU-Seq ([Figure 2D](#fig2){ref-type="fig"}).

![There is a wide range of RNA stabilities, which are positively correlated with translation level in ESCs.\
(**A**) The distribution of mRNA stabilities in ESCs. Dashed lines divide bottom 1%, middle 50%, and top 1% of the data. (**B**) The correlation between sequence features and mRNA stability in ESCs. uORFs (upstream open-reading frames), ARE (AU Rich Elements). (**C**) The correlation between 3' UTR length (log10) and mRNA stability in ESCs. (**D**) (Top) Schematic of dual reporter system to test endogenous 3' UTRs. (Bottom) Normalized median RFP/GFP ratios versus mRNA stability for endogenous genes as measured by 4sU-Seq. Clusters of dots indicate an endogenous 3' UTR, individual dots within a cluster represent biological replicates (n = 3). (**E**) RNA stability of long non-coding RNAs (lncRNAs) compared to protein-coding RNAs. The p value was calculated using the Mann--Whitney test. (**F**) Comparison between mRNA stability and translation level (high polysome/monosome ratio) in ESCs. The p value calculated with correlation significance test. n = 3. See also [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.\
10.7554/eLife.38014.007Figure 2---source data 1.RFP and GFP values for 3' UTR reporters.RFP and GFP intensity values for three individual replicates for 3' UTR reporters ([Figure 2D](#fig2){ref-type="fig"}).](elife-38014-fig2){#fig2}

MiRNAs are one regulatory factor that bind to the 3' UTR of target mRNAs and recruit a complex of proteins that then destabilize the transcripts ([@bib24]; [@bib38]). In ESCs, the embryonic stem-cell-enriched cell cycle (ESCC) family of miRNAs represent a predominant fraction of all miRNAs in ESCs ([@bib28]; [@bib32]; [@bib47]). As expected, ESCC miRNA targets as a group were significantly less stable than all genes (p\<2.22\*10^−16^, Mann-Whitney test) ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). However, a large number of ESCC targets were still in the top 50% of the most stable genes ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). These data suggest that, while miRNAs are strong destabilizers, they can only explain a small portion of the large range of mRNA stabilities seen in the cells.

Interestingly, analysis of the 4sU-Seq data showed that long non-coding RNAs (lncRNAs) were significantly less stable than protein coding genes (p\<2.22\*10^−16^, Mann-Whitney test) ([Figure 2E](#fig2){ref-type="fig"}). This result suggested a strong role for translation in regulating RNA stability in ESCs. To further test this hypothesis, we performed polysome profiling ([@bib1]). While both ribosome profiling and polysome profiling measure global levels of translation, polysome profiling can be a more sensitive measure of translational regulation ([@bib31]). We isolated monosome fractions, low polysome fractions containing 2--4 ribosomes, and high polysome fractions containing 4+ ribosomes and performed RNA-Seq ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). To avoid confusion with the translational efficiency metric measured by ribosome profiling, we refer to the ratio of high polysome/monosome as translation levels. As expected, protein coding genes had a much higher translation level compared to lncRNAs (p\<2.22\*10^−16^, Mann-Whitney test) ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). We next compared the polysome profiling data to the mRNA stability data. There was a highly significant correlation between mRNA stability and translation levels across all genes (Spearman's rho 0.2; p\<2.22\*10^−16^) ([Figure 2F](#fig2){ref-type="fig"}). We also observed a similar pattern when measuring translational efficiency with ribosome profiling data ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). These findings suggested a direct link between translation level and mRNA stability.

Recent reports suggest that differential codon usage is a central mechanism in linking translation to mRNA stability ([@bib3]; [@bib11]; [@bib15]; [@bib52]; [@bib58]). Therefore, we considered the possibility that codon optimality is a driving force in the wide range of mRNA stabilities. Codon optimality is driven in part through tRNA abundance, which is cell type specific in mammals and can alter translation and mRNA stability in a cell-type-specific manner ([@bib26]; [@bib27]). Unfortunately, tRNA abundance data does not exist for ESCs. Instead, we evaluated the frequency of codon usage between mRNAs with differing stabilities. This analysis uncovered small, but significant, differences in codon usage frequency between mRNAs in the top and bottom 20% of stabilities ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}). Therefore, codon optimality may in part explain the link between translation levels and mRNA stability.

DDX6 regulates proliferation and morphology of ESCs {#s2-3}
---------------------------------------------------

In yeast, the protein DHH1 has been shown to link translation to mRNA stability through codon optimality ([@bib61]). The mammalian homolog of DHH1, DDX6, has been shown to associate with both the mRNA decapping and deadenylation complex, also consistent with a potential link between mRNA stability and translation ([@bib14]; [@bib49]; [@bib66]). Therefore, we next asked whether DDX6 may provide a mechanistic link for the relationship between translation and mRNA stability in ESCs. To investigate the function of DDX6 in ESCs, we produced *Ddx6* knockout (*Ddx6* KO) clones using CRISPR-Cas9. Sanger sequencing confirmed a single nucleotide insertion in one clone and a large deletion in a second clone, both of which produce a premature stop ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Western blot confirmed the absence of DDX6 protein in both clones ([Figure 3A](#fig3){ref-type="fig"}). We repeated the 4sU-Seq and polysome profiling in *Ddx6* KO and matched wild-type cells to measure changes in mRNA stability and translation levels. 4sU-Seq and total RNA-Seq showed that while there was a minimal reduction of nascent *Ddx6* mRNA, there was a drastic loss of mature *Ddx6* mRNA in the *Ddx6* KO cells ([Figure 3B](#fig3){ref-type="fig"}). This destabilization is consistent with nonsense-mediated decay and further validates the 4sU-Seq assay for assessing changes in mRNA stability.

![DDX6 regulates proliferation and morphology of ESCs.\
(**A**) Western blot of DDX6 in two *Ddx6* knockout (KO) lines. GAPDH and ACTIN were used as loading controls. (**B**) *Ddx6* counts per million (CPM) in nascent mRNA (4sU) or mRNA in wild-type (WT) and *Ddx6* KO cells. n = 3 for wild-type, n = 4 for *Ddx6* KO (2 replicates of each *Ddx6* KO line) (**C**) Expression of pluripotency genes in *Ddx6* KO ESCs based on RNA-Seq. Error bars represent 95% confidence interval. (**D**) Brightfield images of wild-type and *Ddx6* KO ESCs. Images taken at 20X. (**E**) DDX6 staining in wild-type ESCs. Images taken at 20X. (**F**) P-body staining against DCP1a in wild-type and *Ddx6* KO ESCs. Images taken at 20X. (**G**) Growth curves of wild-type and *Ddx6* KO ESCs in ESC maintenance conditions (LIF/2i). n = 6 for wild-type cells, n = 12 for *Ddx6* KO (six replicates of each *Ddx6* KO line). \* indicates p\<0.05 using a t-test, error bars are standard deviation. See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.](elife-38014-fig3){#fig3}

The loss of DDX6 had little impact on the expression of pluripotency markers ([Figure 3C](#fig3){ref-type="fig"}). However, there were striking morphological changes in the cells ([Figure 3D](#fig3){ref-type="fig"}). Unlike wild-type ESCs which form tight domed colonies, *Ddx6* KO cells grew in a jagged, dispersed monolayer ([Figure 3D](#fig3){ref-type="fig"}). DDX6 localized to discrete punctate in the wild-type cells consistent with P-body localization, as previously reported ([Figure 3E](#fig3){ref-type="fig"}) ([@bib23]; [@bib33]; [@bib51]; [@bib59]). Interestingly, the loss of DDX6 resulted in an abnormal distribution of the P-body marker DCP1a ([Figure 3F](#fig3){ref-type="fig"}). DDX6 loss also led to a reduction in proliferation in self-renewal culture conditions ([Figure 3G](#fig3){ref-type="fig"}). Together, these data show an important role for DDX6 in the formation and/or maintenance of P-bodies and in retaining normal cell morphology and proliferation.

DDX6 separates miRNA-induced translational repression from RNA degradation {#s2-4}
--------------------------------------------------------------------------

Since yeast DHH1 destabilizes lowly translated transcripts enriched in non-optimal codons, we expected that lowly translated genes might be stabilized in *Ddx6* KO ESCs ([@bib61]). However, there was minimal correlation between mRNA stability changes in *Ddx6* KO ESCs and wild-type translation levels (Spearman's rho −0.11; p\<2.22\*10^−16^) ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). The stabilized transcripts were not specifically enriched within the lowly translated transcripts and instead they occurred across all levels of translation. These data suggested that DDX6 does not link mRNA stability with translation levels across all genes. Next, we defined a set of codons as suboptimal based on their enrichment in unstable genes in wild-type ESCs and asked whether they are enriched among genes that are stabilized in *Ddx6* KO cells ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}). There was no enrichment ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Further comparing changes in median codon frequency in stable versus unstable transcripts in wild-type cells with changes in median codon frequency in stabilized versus unstabilized transcripts in *Ddx6* KO cells showed no correlation ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). Species-specific tRNA adaptation index (stAI) provides an alternative metric of codon optimality. The stAI metric takes into account tRNA copy number and a tRNA's ability to wobble base pair with different codons ([@bib61]; [@bib68]). We calculated stAI values for mouse and asked if they could predict changes in transcript stability associated with DDX6 loss. In contrast to the yeast homolog, transcripts stabilized upon DDX6 loss did not correlate with low stAI values ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). These data show that unlike yeast DHH1, the primary function of mammalian DDX6 is not to link codon optimality with transcript stability.

Several aspects of the *Ddx6* KO phenotype, including the cell morphology changes and growth defects, resemble the phenotype of *Dgcr8* KO cells ([@bib77]). DGCR8 is essential for miRNA biogenesis and *Dgcr8* KO ESCs lack all miRNAs ([@bib77]). DDX6 has been implicated as an effector of miRNA activity ([@bib14]; [@bib16]; [@bib49]; [@bib66]). Therefore, we next asked whether *Ddx6* KO cells have similar downstream molecular consequences as *Dgcr8* KO cells. To directly compare the two, we performed 4sU-Seq and polysome profiling in *Dgcr8* KO ESCs and analyzed the data in parallel with that of the *Ddx6* KO ESCs.

The ESCC family of miRNAs represent a predominant fraction of all miRNAs in ESCs ([@bib28]; [@bib32]; [@bib47]; [@bib50]; [@bib76]). They share the 'AAGUGC' seed sequence and thus have common downstream targets. Furthermore, re-introduction of a single member of the ESCC family of miRNAs can revert *Dgcr8* KO cells to a molecular phenotype highly similar to wild-type ESCs ([@bib25]; [@bib50]; [@bib76]). Therefore, we chose to focus on the consequence of DGCR8 loss and DDX6 loss on these targets. As expected, the ESCC targets are stabilized relative to all genes in the *Dgcr8* KO cells ([Figure 4A](#fig4){ref-type="fig"}). However, these same targets showed little change in mRNA stability in the *Ddx6* KO cells ([Figure 4B](#fig4){ref-type="fig"}). Therefore, DDX6 does not appear to play a major role in transcript destabilization downstream of miRNAs.

![DDX6 separates miRNA-induced translational repression from RNA degradation.\
(**A--D**) mRNA stability or translation level changes of ESCC miRNA targets versus all mRNAs. The p value was calculated with Mann-Whitney test. A/B) mRNA stability changes in *Dgcr8* KO (**A**) or *Ddx6* KO (**B**) cells. n = 3 for wild-type, n = 4 for *Ddx6* KO (2 replicates of each *Ddx6* KO line), n = 3 for *Dgcr8* KO. C/D) Translation level changes in *Dgcr8* KO (**C**) or *Ddx6* KO (**D**) cells. n = 3 for each genotype. (**E**) Translation level changes of individual ESCC miRNA targets in *Dgcr8* KO and *Ddx6* KO ESCs. See also [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.](elife-38014-fig4){#fig4}

The loss of DGCR8 also resulted in an increase in the translation levels of ESCC miRNA targets independent of its effect on stability, consistent with miRNAs both inhibiting translation and destabilizing transcripts ([Figure 4C](#fig4){ref-type="fig"}). In contrast to the stability data, the loss of DDX6 had a similar impact as the loss of DGCR8 on the translation levels of ESCC targets ([Figure 4D](#fig4){ref-type="fig"}). Indeed, *Dgcr8* KO and *Ddx6* KO affected the translation levels of individual targets to a similar extent ([Figure 4E](#fig4){ref-type="fig"}). These data show that DDX6 is an essential effector for miRNA-driven translational repression, but not mRNA destabilization. As such, DDX6 separates the two main functions of miRNAs showing that miRNA-driven translational repression and transcript destabilization are not dependent on one another.

Translational repression alone underlies many of the downstream molecular changes associated with miRNA loss {#s2-5}
------------------------------------------------------------------------------------------------------------

Whether translational repression or mRNA destabilization is the predominant effect of miRNAs is controversial as it is difficult to separate the two ([@bib37]; [@bib38]). Given that the *Ddx6* KO cells retained mRNA destabilization, while losing translational repression of miRNA targets, we asked how well derepression of translation matches the downstream consequences of losing all miRNAs. Since the *Ddx6* KO and *Dgcr8* KO cells have partially overlapping phenotypes, we compared global changes in mRNA stability, mRNA levels, and translation levels. Strikingly, while there was little correlation in changes in mRNA stability, changes in both mRNA and translation levels were well correlated ([Figure 5](#fig5){ref-type="fig"}). Nascent transcriptional changes between *Ddx6* KO and *Dgcr8* KO measured by 4sU-Seq are also well correlated ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}) showing that the correlation in mRNA changes is due to transcriptional changes, likely secondary to the direct effects of *Ddx6* and *Dgcr8* loss on the translation of transcriptional regulators. These data show that translational repression alone can explain much of a miRNA's function in ESCs.

![Translational repression alone underlies many of the downstream molecular changes associated with miRNA loss.\
(**A**) Comparison between mRNA stability changes in *Dgcr8* KO versus *Ddx6* KO cells. n = 3 for wild-type, n = 4 for *Ddx6* KO (2 replicates of each *Ddx6* KO line), n = 3 for *Dgcr8* KO. (**B**) Comparison between translation level changes in *Dgcr8* KO versus *Ddx6* KO cells. n = 3 for each genotype. (**C**) Comparison between mRNA changes in *Dgcr8* KO versus *Ddx6* KO cells. The p value was calculated with correlation significance test. (**D**) Summary schematic comparing *Dgcr8* KO cells to *Ddx6* KO cells. *Dgcr8* KO leads to the loss of both translational repression and mRNA destabilization of miRNA targets, while *Ddx6* KO only leads to the loss of translational repression of miRNA targets. mRNA stability is measured as the ratio of mRNA/4sU reads, changes in translation level are measured as the ratio of polysome/monosome reads, protein level changes are not directly measured but are predicted based on mRNA stability and translation level changes. Changes in translation level alone in *Ddx6* KO cells produce similar phenotypes and global molecular changes to *Dgcr8* KO cells. See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}.](elife-38014-fig5){#fig5}

Discussion {#s3}
==========

In this study, we sought to uncover how mRNA stability and translation are regulated within the ESC state and during differentiation. Using RNA-Seq, metabolic labeling (4sU-Seq), and ribosome profiling, we found that most changes during ESC differentiation are driven at the level of transcription. This finding contrasts Lemischka and colleagues' conclusion that post-transcriptional changes underlie many changes in protein levels during ESC differentiation ([@bib45]). The difference may be explained by the different approaches used and the fact that Lemischka and colleagues focused their analysis on nuclear protein changes. Discordant changes between mRNA expression and nuclear protein levels could reflect changes in translational efficiency, protein stability, or protein localization ([@bib44]). We measured translational efficiency, but not post-translational events; therefore, it remains plausible that protein degradation rates or protein localization are dynamic during ESC differentiation.

We found a positive correlation between mRNA stability and translation levels/efficiency in ESCs, similar to what other groups have observed recently in yeast ([@bib11]; [@bib31]; [@bib58]). A number of mechanisms have been proposed. One is that ribosomes sterically hinder the degradation machinery from accessing the transcript. In support of this model, RNA-Seq of the 5' end of decapped RNA degradation intermediates shows a three nucleotide periodicity consistent with exonucleases running into the ribosome on a final round of translation ([@bib57]). Alternatively, some RNA-binding proteins may sense slowly translating transcripts and accelerate their degradation as recently described for DHH1 ([@bib61]). However, in our data, the loss of the mammalian homolog of DHH1, DDX6, did not appear to link low levels of translation with low mRNA stability.

There has been extensive debate about whether miRNAs primarily inhibit translation or induce destabilization of their target transcripts ([@bib37]; [@bib38]). We measure translation as the ratio of polysome reads to monosome reads, which normalizes for any changes in mRNA levels. Therefore, we can independently quantify changes in translation level versus changes in mRNA stability. In *Dgcr8* KO ESCs, which lack all mature miRNAs, we observe that miRNAs both inhibit translation and induce mRNA destabilization of their targets within ESCs. In contrast, the loss of DDX6 only affects the translation of these miRNA targets ([Figure 5D](#fig5){ref-type="fig"}). That is, the number of protein molecules made per target transcript is increased, while the transcript stability remains the same. It has been suggested that translational repression of miRNA targets is the cause of mRNA destabilization or is at least a prerequisite ([@bib62]). However, the *Ddx6* KO cells demonstrate that mRNA destabilization can occur independent of translational repression in a context where both forms of repression normally occur. Future studies will likely identify factors that can decouple translational repression and mRNA destabilization in the other direction so that miRNA targets are translationally repressed without inducing mRNA destabilization. This situation has been observed for synthetic miRNA reporters that cannot undergo deadenylation and subsequent degradation but can still be translationally repressed ([@bib42]). MiRNA-induced translational repression in the absence of mRNA destabilization has also been observed in the early zebrafish embryo, but the mechanism underlying the phenomenon remains unclear ([@bib4])

Our data support a key role for DDX6 in the translational repression of endogenous miRNA targets. Several recent studies implicated DDX6 in the translational repression of miRNA reporters downstream of the CCR4-NOT complex ([@bib14]; [@bib42]; [@bib49]; [@bib66]). These studies found that the DDX6 RecA domain directly interacts with the CNOT1 MIF4G domain ([@bib14]; [@bib49]; [@bib66]). Further, this interaction is important for the translational repression of both CNOT1 tethered reporters and miRNA reporters. In DDX6-depleted cells, repression of a miRNA reporter cannot be rescued by DDX6 mutants that cannot bind to CNOT1 ([@bib14]; [@bib42]; [@bib49]; [@bib66]). Conversely, CNOT1 requires binding to DDX6 in order to repress translation of a reporter that is resistant to deadenylation and degradation, suggesting that DDX6 can repress translation without affecting mRNA levels ([@bib42]; [@bib49]). However, CNOT1 does not require DDX6 to degrade a reporter with a poly(A) tail, suggesting that CCR4-NOT can recruit degradation factors even when the interaction with DDX6 is disrupted ([@bib42]; [@bib49]). Direct tethering of DDX6 represses translation of a reporter and this repression is only mildly disrupted by mutations that prevent DDX6 from interacting with CNOT1 suggesting that DDX6 acts downstream of the CCR4-NOT complex ([@bib42]). These studies also show that CNOT1 directly interacts with CNOT9, which binds to TNRC6, which in turn binds to AGO proteins ([@bib14]; [@bib49]). This binding information directly links miRNA target recognition (AGO-mRNA binding) to translational repression through DDX6, via CNOT1-CNOT9-TNRC6 binding and is consistent with our findings.

It is not fully understood how DDX6 directly represses translation of miRNA targets or if it recruits additional effector molecules. The binding of CNOT1 changes the conformation of DDX6 and stimulates DDX6 ATPase activity ([@bib49]). This ATPase activity is essential for translational repression as DDX6 that contains mutations in the ATPase domain can no longer repress miRNA reporters ([@bib49]). However, how the ATPase domain contributes to translational repression is not known. Experiments using DDX6 tethered to different reporters suggest that DDX6 suppresses translational initiation independent of scanning ([@bib42]). It was recently shown that DDX6 interacts with 4E-T, which competes with eIF4G for binding to the translation initiation factor eIF4E and leads to translational repression ([@bib40]; [@bib54]). Additionally, mutations in the FDF-binding domain of DDX6 prevents interaction with 4E-T and decapping proteins and prevents translational repression of a reporter ([@bib42]). However, depletion of 4E-T only partially alleviates DDX6 mediated translational repression ([@bib39]; [@bib42]). Therefore, DDX6 likely interacts with additional unknown factors to inhibit translation initiation. Our data shows that the loss of DDX6 results in increased translation of miRNA targets to a similar level as the loss of all miRNAs, suggesting that DDX6 serves as a key link between the proteins that repress translation and the rest of the RNA-induced silencing complex.

Surprisingly, the loss of DGCR8 and DDX6 produce similar downstream consequences. Although not directly measured, protein levels of miRNA targets are likely higher in *Dgcr8* KO cells than in *Ddx6* KO cells as the former leads to both mRNA stabilization and translational derepression of miRNA targets, while the later only influences translation ([Figure 5D](#fig5){ref-type="fig"}). Yet, both knockout lines lead to similar morphology and proliferation defects as well as similar downstream molecular changes. It has been argued that mRNA changes are the dominant effect of miRNAs, since miRNA-induced changes in mRNA levels are often larger than changes in translational efficiency ([@bib22]; [@bib29]). However, our data suggest that while miRNAs often have a significant effect on mRNA stability, their impact on translation alone can recapitulate a large portion of the downstream molecular and phenotypic effects associated with miRNA loss.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\           Designation                 Source or reference        Identifiers                                                    Additional information
  (species) or resource                                                                                                                         
  ----------------------- --------------------------- -------------------------- -------------------------------------------------------------- ------------------------------------------------------------
  Gene (Mouse)            Ddx6                        NA                         Ensembl:\                                                      
                                                                                 ENSMUSG00000032097                                             

  Gene (Mouse)            Dgcr8                       NA                         Ensembl:\                                                      
                                                                                 ENSMUSG00000022718                                             

  Cell line (Mouse)       WT (V6.5)\                  PMID: 11331774;\           NBP1-41162                                                     V6.5 mouse embryonic stem cell line\
                          embryonic stem cell         Novus Biologicals                                                                         from the Jaenisch lab, maintained in\
                                                                                                                                                the Blelloch lab. Also available\
                                                                                                                                                commercially from Novus Biologicals.

  Cell line (Mouse)       Dgcr8 KO\                   PMID: 17259983;\           NBA1-19349                                                     Dgcr8 KO mouse embryonic stem cell\
                          embryonic stem cell         Novus Biologicals                                                                         line previously generated in the\
                                                                                                                                                Blelloch lab. Also available\
                                                                                                                                                commercially from Novus Biologicals.

  Cell line (Mouse)       Ddx6 KO\                    This paper                 N/A                                                            Ddx6 KO mouse embryonic stem cell\
                          embryonic stem cell                                                                                                   line generated via CRISPR-Cas9 in the\
                                                                                                                                                Blelloch lab from V6.5 parental cell\
                                                                                                                                                line.

  Cell line (Mouse)       miR290-mCherry and\         PMID: 26212322             N/A                                                            Mouse embryonic stem cell line used\
                          miR302-GFP reporter V6.5\                                                                                             for differentiation in [Figure 1](#fig1){ref-type="fig"}.\
                          embryonic stem cell                                                                                                   Previously generated in the Blelloch\
                                                                                                                                                lab.

  Antibody                anti-DDX6                   Bethyl Lab                 A300-460A-T                                                    1:1000

  Antibody                anti-GAPDH                  Santa Cruz Biotechnology   SC 25778                                                       1:1000

  Antibody                anti-ACTIN                  Sigma                      A4700                                                          1:1000

  Antibody                anti DCP1                   Abcam                      ab47811                                                        1:800

  Recombinant\            pSpCas9(BB)−2A-GFP\         Addgene                    48138                                                          Used to generate DDX6\
  DNA reagent             (PX458) plasmid                                                                                                       KO lines.

  Recombinant\            pBUTR(piggyBac-based 3\'\   PMID: 24753411             N/A                                                            Used for 3\' UTR reporter\
  DNA reagent             UnTranslated Region\                                                                                                  experiments.
                          Reporter) plasmid                                                                                                     

  Sequence-based\         CATGTGGTGATCGCTACCCC        This paper                 N/A                                                            DDX6 KO guide sequence
  reagent                                                                                                                                       

  Commercial\             Ribo-Zero Gold kit          Illumina                   MRZG126                                                        
  assay or kit                                                                                                                                  

  Commercial\             KAPA Stranded RNA-Seq       KAPA                       KK8400                                                         
  assay or kit                                                                                                                                  

  Commercial\             KAPA HyperPrep\             KAPA                       KK8540                                                         
  assay or kit            Stranded RNA-Seq                                                                                                      

  Commercial\             Lexogen QuantSeq 3\' FWD    Lexogen                    015.96                                                         
  assay or kit                                                                                                                                  

  Commercial\             TruSeq Ribosome-Profiling   Illumina                   RPHMR12126                                                     
  assay or kit                                                                                                                                  

  Chemical\               4-thioruridine (4sU)        Sigma                      T4509-100MG                                                    
  compound, drug                                                                                                                                

  Chemical\               Cycloheximide               Sigma                      C4859-1ML                                                      
  compound, drug                                                                                                                                

  Chemical\               Actinomycin D               Fisher Scientific          BP6065                                                         
  compound, drug                                                                                                                                

  Chemical\               MEK inhibitor PD0325901     Peprotech                  3911091                                                        For naïve ESC culture
  compound, drug                                                                                                                                

  Chemical\               GSK3 inhibitor CHIR99021    Peprotech                  2520691                                                        For naïve ESC culture
  compound, drug                                                                                                                                

  Other                   Streptavidin Dynabeads      Invitrogen                 65305                                                          

  Software,\              Cutadapt version 1.14       DOI:10.14806/ej.17.1.200   RRID:[SCR_011841](https://scicrunch.org/resolver/SCR_011841)   
  algorithm                                                                                                                                     

  Software,\              STAR version 2.5.3a         PMID: 23104886             RRID:[SCR_015899](https://scicrunch.org/resolver/SCR_015899)   
  algorithm                                                                                                                                     

  Software,\              Gencode M14 annotation      N/A                        <https://www.gencodegenes.org>                                 
  algorithm                                                                                                                                     

  Software,\              Limma version 3.32.10       PMID: 25605792             RRID:[SCR_010943](https://scicrunch.org/resolver/SCR_010943)   
  algorithm                                                                                                                                     

  Software,\              R version 3.4.2             R Core Team                RRID:[SCR_001905](https://scicrunch.org/resolver/SCR_001905)   
  algorithm                                                                                                                                     

  Software,\              ggplot2 version 2.2.1       H. Wickham                 RRID:[SCR_014601](https://scicrunch.org/resolver/SCR_014601)   
  algorithm                                                                                                                                     

  Software,\              featureCounts\              PMID: 24227677             RRID:[SCR_012919](https://scicrunch.org/resolver/SCR_012919)   
  algorithm               version 1.5.3                                                                                                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Gene accession {#s4-1}
--------------

The accession number for the sequencing data reported in this paper is GEO: GSE112767.

4sU-Sequencing {#s4-2}
--------------

Samples were labeled with 500 uM 4-thiouridine (4sU) (Sigma) for 30 min then extracted with TRIzol (Invitrogen) and split into two groups. rRNA was depleted from Total RNA using the Ribo-Zero Gold kit (Illumina). 80 ug of RNA was biotinylated according to the following protocol [@bib64]. Biotinylated 4sU RNA was isolated and washed using M-270 Streptavidin Dynabeads (Invitrogen), eluted with 100 mM DTT, and cleaned up with RNeasy minelute columns (Qiagen).

Libraries were generated with the KAPA Stranded RNA-Seq or Stranded HyperPrep library prep kit (Kapa) and sequenced with single-end 50 bp reads. Additional rounds of *Ddx6* KO and matched wild-type 4sU samples were sequenced with paired-end reads and counts were merged with single end reads.

Cell culture and differentiation {#s4-3}
--------------------------------

ESCs were grown in Knockout DMEM (Invitrogen) supplemented with 15% Fetal Bovine Serum, LIF and 2i (Peprotech PD0325901 and CHIR99021). In order to generate EpiLCs, 400,000 ESCs were plated in a 15 cm plate; 24 hr later LIF/2i media was removed, cells were washed with PBS, and EpiLCs were collected \~56 hr later ([@bib41]). Cells were tested to be free of mycoplasma.

Quant Seq {#s4-4}
---------

QuantSeq 3' end counting was used for polysome profiling samples as well as matched wild-type, *Ddx6* KO, and *Dgcr8* KO mRNA samples ([Figure 5C](#fig5){ref-type="fig"}). RNA was isolated using RNeasy Micro kits (Qiagen). RNA-Seq libraries were generated using the QuantSeq 3' FWD kit (Lexogen) and sequenced with single-end 50 bp reads.

Ribosome profiling {#s4-5}
------------------

ESCs and EpiLCs were grown as above. Ribosome profiling libraries were generated using the TruSeq Ribosome Profiling kit (Illumina) and sequenced with single-end 50 bp reads. Three nucleotide periodicity of ribosome profiling reads was checked using RiboTaper ([@bib9]). Adapters were trimmed using cutadapt version 1.14 with the following settings: \--minimum-length 26 \--maximum-length 32 for the ribosome protected fragments or \--minimum-length 32 for the total RNA. Adapter sequence used for trimming: AGATCGGAAGAGCACACGTCT. Reads were mapped with STAR version 2.5.3a to the mm10/Gencode M14 genome with the following settings: \--outFilterMultimapNmax 1 \--outFilterMismatchNoverReadLmax 0.05 \--seedSearchStartLmax 13 \--winAnchorMultimapNmax 200.

Polysome profiling {#s4-6}
------------------

Two plates of 6 million V6.5 ESCs were seeded in a 15 cm plate 48 hr prior to collection ([@bib21]). Cells were incubated with 100 ug/ml cycloheximide (Sigma) for 2 min and then moved to ice. Cells were washed and scraped in PBS with cycloheximide, spun down, and then lysed. Lysate was loaded onto a 10--50% sucrose gradient and centrifuged at 35,000 RPM for 3 hr. Gradients were collected on a gradient station (Biocomp). For each sample, the monosome, low polysome (2--4 ribosomes), and high polysome (4 + ribosomes were collected). RNA was extracted from gradient fractions with TRIzol LS (Invitrogen) and concentrated with the Zymo Clean and Concentrator-5 kit (Zymo) prior to library preparation with the QuantSeq 3' FWD kit (Lexogen).

Western blot {#s4-7}
------------

Cells were collected in RIPA buffer with Protease Inhibitor Cocktail (Roche). Protein was run on a 4--15% gel (Bio-Rad) then transferred onto a PVDF membrane. Membranes were blocked with Odyssey blocking buffer, blotted with primary and secondary antibodies, and then imaged on the Odyssey imaging system (LI-COR). Antibodies: DDX6 1:1000 (A300-460A-T), GAPDH 1:1000 (SC 25778), ACTIN 1:1000 (A4700).

Actinomycin D RT-qPCR {#s4-8}
---------------------

Cells were treated with 5 ug/ml Actinomycin D (Fisher Scientific). 0, 2, 4, 6, 8, and 12 hr after treatment, RNA was collected in TRIzol (Invitrogen). Reverse transcription was performed with the Maxima first strand synthesis kit (Thermo Scientific). qPCR was then performed with the SensiFAST SYBR Hi-ROX kit (Bioline) on an ABI 7900HT 384-well PCR machine. Each sample was normalized to 18S rRNA and its 0 hr time point.

Cell count {#s4-9}
----------

50,000 cells were plated in multiple wells of a six well on day 0. On days 1, 2, and 3, cells were trypsinized and counted with a TC20 (Bio-rad). Day 2 and day 3 counts were normalized to the day 1 count.

Imaging {#s4-10}
-------

Cells were fixed with 4% PFA 10 min at room temperature. Cells were blocked with 2% BSA and 1% goat serum in PBST. Cells were incubated with primary antibody for 1 hr at room temperature (Dcp1 abcam (ab47811) antibody 1:800 or DDX6 A300-460A) antibody 1:250). Cells were incubated with goat 488 secondary for 1 hr at room temperature. Cells were then imaged on a Leica inverted fluorescence microscope.

Generation of *Ddx6* KO ESCs {#s4-11}
----------------------------

*Ddx6* KO lines were generated using the protocol from ([@bib63]). A guide RNA (CATGTGGTGATCGCTACCCC) was cloned into PX458, transfected into ESCs using Fugene 6, and then GFP-positive cells were sorted at clonal density. Clones were genotyped with the following primers (Fwd: CATTGCCCAGATTGAAGACA and Rvs: TCCTGACTGGCCTGAAACTT) and verified by western blot. Two different knockout clones were picked and used for all subsequent analysis.

Species-specific tRNA adaptation index calculation {#s4-12}
--------------------------------------------------

For each gene, the CDS region from the Gencode M14 annotation was used. Species-specific tRNA adaptation index (sTAI) values for each gene were calculated with stAIcalc ([@bib69]).

Calculation of codon usage {#s4-13}
--------------------------

For each gene, the APPRIS principle isoform was used to calculate codon usage frequency. To analyze differences in codon usage between stable and unstable genes, codon usage frequency was calculated for genes in the top 20% (stable) and bottom 20% (unstable) in terms of wild-type mRNA stability. For codon usage frequency for mRNA stability changes in *Ddx6* KO cells, we first filtered for genes in the bottom 20% of wild-type stability as defined above. Within those genes, we took the top 20% (top) and bottom 20% (bottom) of mRNA stability changes in *Ddx6* KO ESCs and calculated codon usage frequency within each group. Significant differences in codon frequency were calculated using the Mann--Whitney test followed by Bonferroni correction. For the comparison between codon usage frequency in wild-type versus *Ddx6* KO, we took the median codon usage frequency in stable - the median codon usage frequency in unstable for each codon and compared it to the *Ddx6* KO median codon usage frequency in the bottom group - median codon usage frequency in the top group, using groups as defined above.

Analysis software {#s4-14}
-----------------

For all samples, adapters were trimmed with Cutadapt version 1.14 ([@bib48]) with the following options: -m 20 -a 'A{18}' -a 'T{18}' -a AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC. Reads were mapped with STAR version 2.5.3a ([@bib19]) to the mm10/Gencode M14 genome with the following settings: \--outFilterMultimapNmax 1 \--outFilterMismatchNoverReadLmax 0.05 \--seedSearchStartLmax 25 \--winAnchorMultimapNmax 100. Reads were counted with featureCounts version 1.5.3 ([@bib43]) using the Gencode M14 annotation with rRNA annotations removed with the following settings: -s. Differential expression was carried out with limma version 3.32.10 ([@bib65]) and R version 3.4.2. Genes with a low number of reads were filtered out: a gene must have at least three counts per million across at least three replicates to be included for differential expression. For samples with multiple comparisons, a linear model was used for each condition in limma taking into account assay type (e.g. 4sU versus total RNA) and cell type (e.g. KO versus wild-type); significant changes in stability or translation are based on the interaction term. All downstream analyses were performed in R version 3.4.2 and plotted with ggplot2 version 2.2.1.

Polysome profiling analysis {#s4-15}
---------------------------

RNA-Seq from the monosome, low polysome (2--4 ribosomes), and high polysome (4 + ribosomes were collected) fractions was mapped as above. Translation level was defined as the ratio of the high polysome counts divided by the monosome counts. For KO versus wild-type analysis, a linear model was used for each condition in limma and significant changes in translation are based on the interaction term.

4sU-Seq analysis {#s4-16}
----------------

By measuring transcription rate and steady state mRNA levels, it is possible to infer the relative degradation rate ([@bib60]). It is assumed that across the population of cells there is no change in mRNA levels over time for a given state. Therefore, changes mRNA levels can be modeled by their production rate $\alpha$ and degradation rate $\beta$.$$\mathbf{d}\mathbf{m}\mathbf{R}\mathbf{N}\mathbf{A}/\mathbf{d}\mathbf{t}\mathbf{} = \mathbf{}\mathbf{\alpha}\mathbf{} - \mathbf{}\mathbf{\beta}\left\lbrack \mathbf{m}\mathbf{R}\mathbf{N}\mathbf{A} \right\rbrack\mathbf{} \approx \mathbf{}0$$

Solving for this equation, degradation rates can be calculated using a production rate (in this case nascent RNA transcription as measured by 4sU incorporation) and the concentration of total mRNA in the cell (as measured by total RNA-Seq).$$\alpha/\left\lbrack \mathbf{m}\mathbf{R}\mathbf{N}\mathbf{A} \right\rbrack\mathbf{} \approx \mathbf{}\mathbf{\beta}$$

For KO versus wild-type analysis, a linear model was used for each condition in limma and significant changes in stability are based on the interaction term.

Analysis of features regulating RNA stability {#s4-17}
---------------------------------------------

For each gene with multiple isoforms, the APPRIS principle isoform was used. APPRIS data were downloaded on 10/30/2017. Log10(feature lengths), GC %, and log10(number of exons) were calculated in R version 3.4.2. Upstream open-reading frames were defined as the number of ATG sequences in the 5' UTR. AU-rich elements were defined as the number of UAUUUAU sequences in the 3' UTR. miRNA sites were defined as below. Each of these features and mRNA stability were used in a multiple linear regression using the lm function in R version 3.4.2. Additionally, the Spearman correlation was calculated between each feature and mRNA stability.

microRNA targets {#s4-18}
----------------

Conserved microRNA targets were downloaded from Targetscan mouse release 7.1. This list was filtered for genes that are targeted by the miR-291--3 p/294--3 p/295--3 p/302--3 p family yielding 765 target genes.

3' UTR analysis {#s4-19}
---------------

For each gene, the APPRIS principle isoform was used to calculate log10 (3' UTR length). Log10(3' UTR length) was then compared to log2 relative mRNA stability.

3' UTR reporters {#s4-20}
----------------

Endogenous 3' UTRs from the following genes were amplified from ESC cDNA: ENSMUSG00000021583, ENSMUSG00000029580, ENSMUSG00000043716, ENSMUSG00000010342, ENSMUSG00000021665, ENSMUSG00000024406, ENSMUSG00000052911, ENSMUSG00000058056, ENSMUSG00000020105, ENSMUSG00000026003, ENSMUSG00000020038, ENSMUSG00000025521, ENSMUSG00000031503. Genes were cloned into the pBUTR (piggyBac-based 3′ UnTranslated Region reporter) using gateway cloning as outlined in [@bib12]. Reporters were transfected into ESCs using Fugene 6 (Promega). Cells were treated with Genenticin to enrich for transfected cells. Cells were analyzed on an LSRII (BD). RFP+/GFP+ cells were gated in FlowJo and median RFP/GFP ratios were calculated. RFP/GFP ratios were standardized between days to accounts for differences in laser power.

Primers {#s4-21}
-------

GeneForwardReverseGapdhAGGTCGGTGTGAACGGATTTGTGTAGACCATGTAGTTGAGGTCANanogAACCAAAGGATGAAGTGCAAGCGGTCCAAGTTGGGTTGGTCCAAGTCTZfp42CTCCTGCACACAGAAGAAAGCCACTGATCCGCAAACACCFgf5CCTTGCGACCCAGGAGCTTACCGTCTGTGGTTTCTGTTGAGGOtx2CAACTTGCCAGAATCCAGGGGGCCTCACTTTGTTCTGACCBakgctgacatgtttgctgatgggatcagctcgggcactttagDdx6 qPCRACTATACTCCGCTACTTTCCCTCTGGCGCTCCGTTACATATG18SGTGGAGCGATTTGTCTGGTTCGCTGAGCCAGTCAGTGTAGMycNAGTGTGTCTGTTCCAGCTACTGTTCATCTTCCTCCTCGTCATCCPgap1AGTACCCCGAGTACCAGAAAATTCGAACTTGCTTATAGCTTCCAGImpactGTGAAGAAATCGAAGCAATGGCGGTACTCACTTGGCAACATCACyr61AACGAGGACTGCAGCAAAACTTCTGACTGAGCTCTGCAGATCAmotl2AGGGACAATGAGCGATTGCAGCCTCACGCTTGGAAGAGGTDdx6 GenotypingCATTGCCCAGATTGAAGACATCCTGACTGGCCTGAAACTT
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The following dataset was generated:

Freimer JWHu TBlelloch R2018Decoupling the impact of microRNAs on translational repression versus RNA degradation in embryonic stem cells[www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112767](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112767)Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE112767).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Decoupling the impact of microRNAs on translational repression versus RNA degradation in embryonic stem cells\" for consideration by *eLife*. Your article has been reviewed by James Manley as the Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This is a very interesting and well-documented study, which demonstrates that translational efficiency of mRNAs in ESCs is closely positively correlated with their stability. The authors further demonstrate that depletion of the RNA helicase DDX6 does not eliminate this correlation what contrasts with the situation in yeast. The most important finding of the work is the demonstration that knock-out of *Ddx6* in ESCs relieves translational repression induced by miRNAs and that the phenotype of *Ddx6* KO cells is similar to that of cells in which miRNA population is eliminated through inactivation of DGCR8. This data provides very strong support to the notion that translational repression by miRNAs may represent a decisive factor explaining their biological function (at least in ESCs), and that DDX6 is a major mediator of the translational repression by miRNAs. Additionally, the authors find that during ESC differentiation transcriptional changes drive gene expression changes, which contrasts with conclusions from previous studies performed in Lemischa\'s lab.

Essential revisions:

The paper would be strengthened by additional work and better explanation some of the data as follows:

1\) The authors frequently note that lower mRNA stability is related to the lower translation efficiency. Could they show such relationship within their own datasets? Also, what would be the possible complications of the interpretation of their own TE data?

2\) There is a confusing aspect in that the authors report upregulation in translation of miRNA targets without an increase in mRNA stability; this is mechanistically counterintuitive. If a miRNA-targeted mRNA is not destabilized, then a change in translational repression is anticipated, as has been reported in zebrafish embryos. In sharp contrast, the authors report that miRNA targets are still being destabilized but their translation rates are upregulated. How can an mRNA that is being destabilized have higher rates of translation? DDX6 contact with the CCR4-NOT complex has been linked to \'pure\' translational repression; however, this is always assessed in the context of a miRNA-targeted reporter mRNA that cannot be deadenylated and is therefore highly stable. This is in contrast to endogenous miRNA targets that can be deadenylated and degraded. Overall, the conclusion that translational repression can be separated from mRNA destabilization needs to be better explained in reference to the existing literature.

3\) The authors should include in the Discussion section a paragraph better describing previous work demonstrating the involvement of DDX6 in translational repression by miRNAs. Although some of the studies are mentioned in two sentences in the Introduction and Results section, it would also be interesting to discuss (for example, in the Discussion section), that the role of DDX6 is documented by structural studies (Chen et al., 2014, Mathys et al., 2014), importance of the CNOT1 \~ DDX6 interaction for activation of the DDX6 ATPase activity, which in turn is needed for translational repression (Mathys et al., 2014; Kuzyoglu-Ozturk et al., 2016). A better discussion of the DDX6 role would make the paper more interesting to the wide readership.

4\) Subsection "There is a wide range of RNA stabilities which are positively correlated with translation in ESCs". \"To avoid confusion...\", the authors use the term \"translational levels\" here to distinguish it from the translational efficiency metric measured by ribosome profiling. However, in subsection "Transcriptional changes drive expression changes during the ESC to EpiLC transition" and elsewhere they use the term \"levels\" for ribosome profiling data. Be consistent!

5\) Subsection "DDX6 regulates proliferation and morphology of ESCs" and corresponding figures. It is difficult to appreciate how big are the differences in codon optimality between the top and the bottom 20% of mRNAs. Can some statistical significance be provided for this data? Or, give some information about which codons/tRNA are rare and which are not.

6\) Subsection "Translational repression alone underlies many of the downstream molecular changes associated with miRNA loss". It is concluded, \"The correlation in mRNA changes is likely due to transcriptional secondary effects....\" Any data supporting this? Evidence of an increase in pre-mRNA or IVS-containing reads?

7\) Discussion section. A similar situation was also observed with reporters which are prevented to undergo decay (see, for example, Kuzuoglu-Ozturk et al., 2016).

8\) Many references are listed multiple times in the references list.

10.7554/eLife.38014.019

Author response

> Summary:
>
> This is a very interesting and well-documented study, which demonstrates that translational efficiency of mRNAs in ESCs is closely positively correlated with their stability. The authors further demonstrate that depletion of the RNA helicase DDX6 does not eliminate this correlation what contrasts with the situation in yeast. The most important finding of the work is the demonstration that knock-out of Ddx6 in ESCs relieves translational repression induced by miRNAs and that the phenotype of Ddx6 KO cells is similar to that of cells in which miRNA population is eliminated through inactivation of DGCR8. This data provides very strong support to the notion that translational repression by miRNAs may represent a decisive factor explaining their biological function (at least in ESCs), and that DDX6 is a major mediator of the translational repression by miRNAs. Additionally, the authors find that during ESC differentiation transcriptional changes drive gene expression changes, which contrasts with conclusions from previous studies performed in Lemischa\'s lab.

We thank the reviewers for their interest and helpful suggestions. We have incorporated their feedback and added new graphs as well as added new text, both of which have improved the manuscript. We discuss the specific changes below.

> Essential revisions:
>
> The paper would be strengthened by additional work and better explanation some of the data as follows:
>
> 1\) The authors frequently note that lower mRNA stability is related to the lower translation efficiency. Could they show such relationship within their own datasets? Also, what would be the possible complications of the interpretation of their own TE data?

To complement Figure 2F showing the positive correlation between mRNA stability and translation level as measured by polysome profiling, we have made a similar scatter plot with translation efficiency as measured by the ribosome profiling data. Similar to when using translation level, translation efficiency shows a positive correlation with mRNA stability which is now shown in Figure 2---figure supplement 1D. We are not aware of complications of the interpretation of our translational efficiency data; if the reviewers think we are missing something we would be happy to take it into account.

> 2\) There is a confusing aspect in that the authors report upregulation in translation of miRNA targets without an increase in mRNA stability; this is mechanistically counterintuitive. If a miRNA-targeted mRNA is not destabilized, then a change in translational repression is anticipated, as has been reported in zebrafish embryos. In sharp contrast, the authors report that miRNA targets are still being destabilized but their translation rates are upregulated. How can an mRNA that is being destabilized have higher rates of translation? DDX6 contact with the CCR4-NOT complex has been linked to \'pure\' translational repression; however, this is always assessed in the context of a miRNA-targeted reporter mRNA that cannot be deadenylated and is therefore highly stable. This is in contrast to endogenous miRNA targets that can be deadenylated and degraded. Overall, the conclusion that translational repression can be separated from mRNA destabilization needs to be better explained in reference to the existing literature.

The translation rates measured are relative translation rates normalized for mRNA levels. We have now clarified this issue in the text.

> 3\) The authors should include in the Discussion section a paragraph better describing previous work demonstrating the involvement of DDX6 in translational repression by miRNAs. Although some of the studies are mentioned in two sentences in the Introduction and Results section, it would also be interesting to discuss (for example, in the Discussion section), that the role of DDX6 is documented by structural studies (Chen et al., 2014, Mathys et al., 2014), importance of the CNOT1 \~ DDX6 interaction for activation of the DDX6 ATPase activity, which in turn is needed for translational repression (Mathys et al., 2014; Kuzyoglu-Ozturk et al., 2016). A better discussion of the DDX6 role would make the paper more interesting to the wide readership.

We thank the reviewers for these suggestions. We have revisited these papers and have expanded our discussion to better discuss the previous literature regarding the role of DDX6 in the translational repression of miRNA reporters and the interaction of DDX6 with the CCR4-NOT complex.

> 4\) Subsection "There is a wide range of RNA stabilities which are positively correlated with translation in ESCs". \"To avoid confusion...\", the authors use the term \"translational levels\" here to distinguish it from the translational efficiency metric measured by ribosome profiling. However, in subsection "Transcriptional changes drive expression changes during the ESC to EpiLC transition" and elsewhere they use the term \"levels\" for ribosome profiling data. Be consistent!

We apologize for this oversight. We have gone through the manuscript and changed the text in several places to only use translational efficiency when referring to ribosome profiling data and to only use translation levels when referring to polysome profiling data.

> 5\) Subsection "DDX6 regulates proliferation and morphology of ESCs" and corresponding figures. It is difficult to appreciate how big are the differences in codon optimality between the top and the bottom 20% of mRNAs. Can some statistical significance be provided for this data? Or, give some information about which codons/tRNA are rare and which are not.

We have added statistical significance for differences in codon frequency using the Mann--Whitney test followed by Bonferroni correction.

Codon optimality is driven in part through tRNA abundance, which is cell type specific in mammals and can alter translation and mRNA stability in a cell type specific manner (Goodarzi et al., 2016; Gingold et al., 2014). Unfortunately, tRNA abundance data does not exist for ESCs making it impossible to definitively assign codons/tRNA as rare or not in ESCs. To get around this problem when analyzing the *Ddx6* KO data, we focused on codons that were enriched in unstable genes in wild-type cells and asked if they were enriched in genes that were stabilized in *Ddx6* KO cells. They were not (Figure 4---figure supplement 1B). Therefore, *Ddx6* does not appear to be destabilizing these transcripts secondary to their codon usage. We have clarified these points in the text.

> 6\) Subsection "Translational repression alone underlies many of the downstream molecular changes associated with miRNA loss". It is concluded, \"The correlation in mRNA changes is likely due to transcriptional secondary effects....\" Any data supporting this? Evidence of an increase in pre-mRNA or IVS-containing reads?

We have added a new figure, Figure 5---figure supplement 1A, showing that changes in nascent RNA (4sU-Seq) between *Dgcr8* KO and *Ddx6* KO are also well correlated. This data, together with the lack of correlation for stability changes (Figure 5A), support the claim that the correlated mRNA changes are due to transcriptional effects and not due to changes in post-transcriptional regulation. We have updated that sentence to include the new data and it now reads "Nascent transcriptional changes between *Ddx6* KO and *Dgcr8* KO measured by 4sU-Seq are also well correlated (Figure 5---figure supplement 1A) showing that the correlation in mRNA changes is due to transcriptional changes, likely secondary to the direct effects of *Ddx6* and *Dgcr8* loss on the translation of transcriptional regulators."

> 7\) Discussion section. A similar situation was also observed with reporters which are prevented to undergo decay (see, for example, Kuzuoglu-Ozturk et al., 2016).

We apologize for this oversight. We have added a sentence discussing these reporters and citing Kuzuoglu-Ozturk et al. This section now reads: "This situation has been observed for synthetic miRNA reporters that cannot undergo deadenylation and subsequent degradation but can still be translationally repressed (Kuzuoğlu-Öztürk et al., 2016). MiRNA induced translational repression in the absence of mRNA destabilization has also been observed in the early zebrafish embryo, but the mechanism underlying the phenomenon remains unclear (Bazzini et al., 2012)."

> 8\) Many references are listed multiple times in the references list.

We apologize for this oversight. All duplicate references have been removed.
